问 感受一下WPS的AI数字人播报的魅力

北京创立科创医药技术开发有限公司成立于2003年3月，是专注于医药产品研发(中药/化药/保健食品)、临床试 验管理( GCP/CRA/CRC)、注册申报咨询服务(药品/保健食品/医疗器械)的综合性合同研究组织( All-aroundCRO)。

公司致力于医药产品的研究开发和技术服务，在药品、保健食品、医疗器械的研究开发、临床试验管理、注册申报及产品上市后的研究与评价领域提供整体研究方案与服务。公司研发团队整体优势突出，多年来药学、临床学、药理学、统计学等专业团队在研发项目的设计，实施中发挥了多学科支持的优势。面向中国、亚太地区以及全球提供本地化 与国际化结合的专业服务。

迄今为止，我们已经完成1000余个项目。涉及呼吸科、儿科、心血管科、脑和神经、免疫和过敏、骨科、皮肤科、妇科、肿瘤科、眼科和抗感染等方面的领域。我们根据客户需求，准确把握药物特点，设计最优的研究方案，最大限度挖掘产品潜在的价值。从临床前的药物研究到临床Ⅰ期到IV 期研究，我们提供全方位、多维度的专业服务。

科技为先，服务为本，我们始终坚持以明锐的目光捕捉最新的技术，以踏实肯干的精神为客户提供最优质的医药类专业服务。

Beijing Chuangke Pharmaceutical Technology Development Co., Ltd. was established in March 2003 and is a comprehensive contract research organization (All-around CRO) specializing in pharmaceutical product development (traditional Chinese medicine, chemical drugs, health foods), clinical trial management (GCP, CRA, CRC), and registration submission consulting services (drugs, health foods, medical devices).

The company is dedicated to the research, development, and technical services of pharmaceutical products, providing comprehensive research solutions and services in the areas of drug development, health food development, medical device R&D, clinical trial management, regulatory submission, as well as post-market product evaluation. The company's R&D team boasts outstanding overall strengths; over the years, specialized teams in pharmacy, clinical science, pharmacology, and statistics have leveraged multidisciplinary expertise throughout the design and implementation of R&D projects. The company offers professional services that combine localization with internationalization for China, the Asia-Pacific region, and globally.

To date, we have completed over 1,000 projects spanning various clinical disciplines including respiratory medicine, pediatrics, cardiology, neurology, immunology and allergy, orthopedics, dermatology, gynecology, oncology, ophthalmology, and anti-infective therapy. Tailoring our approach to client needs, we meticulously analyze drug characteristics to develop optimal research strategies that maximize product potential value. From preclinical drug development through Phase I to Phase IV clinical trials, we provide comprehensive, multidimensional professional services.

With technology as our priority and service as our foundation, we consistently employ a forward-looking perspective to identify the latest advancements in technology and deliver top-tier pharmaceutical professional services to our clients through a diligent and dedicated approach.